Synovial Fibroblast 3.1: Secretion response of seven primary human synovial fibroblast samples from healthy and rheumatoid arthritis donors to a panel of 3 stimuli and 5 small molecule inhibitors (replicate 1 of 2) - Dataset (ID:20234)
- Detail
- Small Molecules Studied
- Primary Cells Studied
- Proteins Studied
- Unclassified Perturbagens Studied
- Data Columns
- Results
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Protein Stimulus | Other Stimulus | Stimulus Concentration | Stimulus Conc Unit | ExpPlate | Measured Protein | Measured Protein MFI (a.u.) | Bead Count |
---|---|---|---|---|---|---|---|---|---|---|---|
RA2708 | PH-797804 | 0.6 | uM | 2 | GRO-a | 1667.5 | 26 | ||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 84.0 | 50 | ||||
RA2159 | IKK16 | 2.0 | uM | 2 | GRO-a | 186.5 | 56 | ||||
N2645 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 43.0 | 37 | ||||
N2645 | IKK16 | 2.0 | uM | 2 | GRO-a | 41.0 | 39 | ||||
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | 2 | GRO-a | 947.0 | 43 | ||||
RA2708 | IKK16 | 2.0 | uM | 2 | GRO-a | 1522.0 | 49 | ||||
RA2159 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 231.0 | 33 | ||||
RA2159 | 2 | GRO-a | 257.5 | 64 | |||||||
N2645 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 47.0 | 60 | ||||
N2645 | 2 | GRO-a | 49.0 | 50 | |||||||
RA2708 | Tofacitinib | 0.3 | uM | 2 | GRO-a | 2278.0 | 39 | ||||
RA2708 | 2 | GRO-a | 2454.0 | 33 | |||||||
RA2159 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 527.5 | 40 | |
RA2159 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 5670.0 | 56 | |
N2645 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 69.0 | 53 | |
N2645 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 163.5 | 46 | |
RA2708 | 5z-7-oxozeaenol | 0.6 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 1559.5 | 48 | |
RA2708 | IKK16 | 2.0 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 6074.0 | 40 | |
RA2159 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 10426.0 | 35 | |
RA2159 | TNF-a | 100 | ng/mL | 2 | GRO-a | 10250.5 | 50 | ||||
N2645 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 734.0 | 43 | |
N2645 | TNF-a | 100 | ng/mL | 2 | GRO-a | 1082.0 | 55 | ||||
RA2708 | Tofacitinib | 0.3 | uM | TNF-a | 100 | ng/mL | 2 | GRO-a | 11472.0 | 35 | |
RA2708 | TNF-a | 100 | ng/mL | 2 | GRO-a | 12212.0 | 27 |